Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adrenoleukodystrophy | 45 | 2024 | 143 | 17.940 |
Why?
|
Leukodystrophy, Metachromatic | 12 | 2024 | 44 | 3.780 |
Why?
|
Hereditary Sensory and Autonomic Neuropathies | 7 | 2024 | 41 | 2.160 |
Why?
|
Sphingolipids | 10 | 2024 | 173 | 2.010 |
Why?
|
Serine C-Palmitoyltransferase | 9 | 2024 | 42 | 1.730 |
Why?
|
ATP-Binding Cassette Transporters | 6 | 2023 | 563 | 1.650 |
Why?
|
Cystinosis | 3 | 2022 | 26 | 1.590 |
Why?
|
Adrenal Insufficiency | 5 | 2023 | 192 | 1.580 |
Why?
|
Hereditary Central Nervous System Demyelinating Diseases | 6 | 2020 | 42 | 1.540 |
Why?
|
Genetic Vectors | 7 | 2024 | 3380 | 1.520 |
Why?
|
Gangliosidoses, GM2 | 6 | 2024 | 20 | 1.450 |
Why?
|
Lentivirus | 3 | 2024 | 506 | 1.440 |
Why?
|
Leukoencephalopathies | 5 | 2017 | 249 | 1.170 |
Why?
|
Serine | 6 | 2022 | 830 | 1.170 |
Why?
|
Hematopoietic Stem Cell Transplantation | 13 | 2024 | 5649 | 1.140 |
Why?
|
Dependovirus | 5 | 2022 | 709 | 1.090 |
Why?
|
Lysosomal Storage Diseases | 4 | 2022 | 79 | 1.080 |
Why?
|
Canavan Disease | 2 | 2024 | 6 | 1.020 |
Why?
|
Distal Myopathies | 2 | 2020 | 18 | 0.880 |
Why?
|
Neonatal Screening | 8 | 2024 | 595 | 0.860 |
Why?
|
Cost of Illness | 4 | 2024 | 1940 | 0.860 |
Why?
|
Neurodegenerative Diseases | 4 | 2024 | 1084 | 0.850 |
Why?
|
Demyelinating Diseases | 6 | 2017 | 351 | 0.840 |
Why?
|
Nerve Fibers, Myelinated | 4 | 2012 | 952 | 0.800 |
Why?
|
Sphingosine | 3 | 2019 | 308 | 0.780 |
Why?
|
Myelin Sheath | 3 | 2024 | 652 | 0.780 |
Why?
|
Xanthomatosis, Cerebrotendinous | 2 | 2018 | 9 | 0.780 |
Why?
|
Brain | 23 | 2024 | 26951 | 0.760 |
Why?
|
Diabetic Neuropathies | 2 | 2022 | 406 | 0.740 |
Why?
|
Nervous System Diseases | 2 | 2024 | 1647 | 0.730 |
Why?
|
Spinal Cord Diseases | 2 | 2021 | 293 | 0.730 |
Why?
|
Deglutition Disorders | 3 | 2022 | 626 | 0.720 |
Why?
|
Magnetic Resonance Imaging | 29 | 2024 | 36290 | 0.700 |
Why?
|
Vision Disorders | 2 | 2024 | 1084 | 0.690 |
Why?
|
Restless Legs Syndrome | 1 | 2022 | 233 | 0.640 |
Why?
|
Astrocytes | 2 | 2024 | 1338 | 0.630 |
Why?
|
Muscular Diseases | 2 | 2020 | 551 | 0.620 |
Why?
|
Chenodeoxycholic Acid | 1 | 2018 | 34 | 0.610 |
Why?
|
Blood-Brain Barrier | 3 | 2017 | 1019 | 0.610 |
Why?
|
Neural Conduction | 3 | 2019 | 441 | 0.610 |
Why?
|
Disease Progression | 18 | 2024 | 13502 | 0.600 |
Why?
|
Basal Ganglia Diseases | 1 | 2017 | 144 | 0.570 |
Why?
|
Urinary Tract | 1 | 2021 | 309 | 0.570 |
Why?
|
Eukaryotic Initiation Factor-2B | 1 | 2016 | 9 | 0.550 |
Why?
|
Child | 40 | 2024 | 79806 | 0.540 |
Why?
|
Aspartic Acid | 3 | 2024 | 576 | 0.540 |
Why?
|
Receptor, Macrophage Colony-Stimulating Factor | 1 | 2016 | 94 | 0.530 |
Why?
|
Visual Perception | 1 | 2024 | 1374 | 0.530 |
Why?
|
Gene Transfer Techniques | 3 | 2021 | 1204 | 0.510 |
Why?
|
Fatty Acids | 8 | 2022 | 1804 | 0.510 |
Why?
|
Age of Onset | 8 | 2024 | 3301 | 0.510 |
Why?
|
Neuroblastoma | 1 | 2023 | 1252 | 0.500 |
Why?
|
Humans | 119 | 2024 | 760621 | 0.500 |
Why?
|
Growth Cones | 1 | 2015 | 117 | 0.490 |
Why?
|
Microglia | 3 | 2017 | 1351 | 0.490 |
Why?
|
Magnetic Resonance Spectroscopy | 7 | 2016 | 3765 | 0.490 |
Why?
|
Ovarian Diseases | 1 | 2016 | 137 | 0.490 |
Why?
|
Hematopoietic Stem Cells | 3 | 2024 | 3387 | 0.480 |
Why?
|
Developmental Disabilities | 6 | 2024 | 1504 | 0.480 |
Why?
|
Leukodystrophy, Globoid Cell | 2 | 2011 | 38 | 0.480 |
Why?
|
Transduction, Genetic | 3 | 2021 | 897 | 0.470 |
Why?
|
Dystonia | 1 | 2017 | 364 | 0.470 |
Why?
|
Male | 67 | 2024 | 359744 | 0.460 |
Why?
|
Hyperglycemia | 1 | 2022 | 1380 | 0.460 |
Why?
|
Adolescent | 29 | 2024 | 87810 | 0.460 |
Why?
|
Neurotoxins | 2 | 2011 | 240 | 0.440 |
Why?
|
Tay-Sachs Disease | 4 | 2024 | 20 | 0.430 |
Why?
|
Nonlinear Dynamics | 1 | 2015 | 494 | 0.430 |
Why?
|
Brain Diseases | 8 | 2019 | 1540 | 0.420 |
Why?
|
Ganglia, Spinal | 1 | 2015 | 523 | 0.420 |
Why?
|
Mosaicism | 1 | 2016 | 466 | 0.420 |
Why?
|
Adult | 44 | 2024 | 219994 | 0.410 |
Why?
|
Spastic Paraplegia, Hereditary | 3 | 2024 | 168 | 0.410 |
Why?
|
Young Adult | 21 | 2024 | 58741 | 0.400 |
Why?
|
Mutation | 17 | 2024 | 29932 | 0.400 |
Why?
|
Membrane Transport Proteins | 1 | 2017 | 1035 | 0.400 |
Why?
|
Clinical Trials as Topic | 3 | 2024 | 8056 | 0.380 |
Why?
|
Microvessels | 1 | 2015 | 572 | 0.370 |
Why?
|
Amino Acid Metabolism, Inborn Errors | 3 | 2015 | 282 | 0.370 |
Why?
|
Child, Preschool | 20 | 2024 | 42063 | 0.350 |
Why?
|
Seizures | 3 | 2017 | 2917 | 0.350 |
Why?
|
Rare Diseases | 3 | 2024 | 619 | 0.350 |
Why?
|
Metabolic Diseases | 2 | 2018 | 686 | 0.350 |
Why?
|
Retrospective Studies | 17 | 2024 | 80372 | 0.350 |
Why?
|
Sulfite Oxidase | 2 | 2006 | 10 | 0.350 |
Why?
|
Cerebrovascular Circulation | 5 | 2017 | 2733 | 0.340 |
Why?
|
Brain Diseases, Metabolic, Inborn | 2 | 2006 | 45 | 0.330 |
Why?
|
Caregivers | 3 | 2022 | 2224 | 0.330 |
Why?
|
Infant, Newborn | 18 | 2024 | 26181 | 0.310 |
Why?
|
Severity of Illness Index | 9 | 2024 | 15840 | 0.310 |
Why?
|
Mutation, Missense | 4 | 2024 | 2566 | 0.310 |
Why?
|
Female | 51 | 2024 | 391270 | 0.310 |
Why?
|
Charcot-Marie-Tooth Disease | 2 | 2022 | 96 | 0.310 |
Why?
|
Animals | 24 | 2024 | 167963 | 0.290 |
Why?
|
Gliosis | 1 | 2008 | 244 | 0.290 |
Why?
|
Infant | 20 | 2024 | 36060 | 0.290 |
Why?
|
Protein Subunits | 2 | 2009 | 943 | 0.280 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2007 | 110 | 0.270 |
Why?
|
Cerebroside-Sulfatase | 2 | 2024 | 15 | 0.270 |
Why?
|
Creatine | 4 | 2015 | 426 | 0.260 |
Why?
|
Mice | 15 | 2024 | 81208 | 0.260 |
Why?
|
Gene Expression | 4 | 2017 | 7588 | 0.260 |
Why?
|
Middle Aged | 27 | 2024 | 220352 | 0.260 |
Why?
|
Phenotype | 6 | 2021 | 16546 | 0.250 |
Why?
|
Family | 1 | 2016 | 3189 | 0.250 |
Why?
|
Treatment Outcome | 11 | 2024 | 65017 | 0.240 |
Why?
|
Metabolism, Inborn Errors | 2 | 2017 | 285 | 0.240 |
Why?
|
Neurons | 5 | 2023 | 9426 | 0.240 |
Why?
|
Nervous System Malformations | 2 | 2024 | 244 | 0.240 |
Why?
|
Encephalitis | 1 | 2008 | 437 | 0.230 |
Why?
|
Amidohydrolases | 2 | 2024 | 162 | 0.230 |
Why?
|
Diabetes Mellitus | 1 | 2022 | 5889 | 0.230 |
Why?
|
Lysophosphatidylcholines | 2 | 2017 | 77 | 0.220 |
Why?
|
Cholinergic Agents | 1 | 2023 | 96 | 0.220 |
Why?
|
Autoimmune Diseases of the Nervous System | 1 | 2024 | 75 | 0.220 |
Why?
|
Endothelium, Vascular | 1 | 2015 | 4433 | 0.220 |
Why?
|
Disease Models, Animal | 5 | 2024 | 18137 | 0.210 |
Why?
|
Neurofilament Proteins | 2 | 2023 | 333 | 0.210 |
Why?
|
Spinal Cord | 3 | 2021 | 1817 | 0.200 |
Why?
|
Herpesviridae | 1 | 2022 | 106 | 0.200 |
Why?
|
Heterozygote | 4 | 2015 | 2798 | 0.200 |
Why?
|
Peroxisomes | 1 | 2022 | 68 | 0.190 |
Why?
|
Nervous System | 1 | 2024 | 543 | 0.190 |
Why?
|
Skin | 1 | 2015 | 4466 | 0.190 |
Why?
|
Alanine | 2 | 2015 | 606 | 0.190 |
Why?
|
Homozygote | 3 | 2016 | 1788 | 0.190 |
Why?
|
Stearoyl-CoA Desaturase | 1 | 2021 | 85 | 0.180 |
Why?
|
Cause of Death | 1 | 2011 | 3725 | 0.180 |
Why?
|
Microcirculation | 2 | 2017 | 1278 | 0.180 |
Why?
|
RNA, Messenger | 1 | 2015 | 12766 | 0.180 |
Why?
|
Breathing Exercises | 1 | 2020 | 60 | 0.180 |
Why?
|
Cells, Cultured | 4 | 2017 | 18957 | 0.170 |
Why?
|
Corpus Callosum | 2 | 2019 | 749 | 0.170 |
Why?
|
Macula Lutea | 2 | 2019 | 169 | 0.170 |
Why?
|
Quality of Life | 5 | 2024 | 13308 | 0.170 |
Why?
|
Prevalence | 4 | 2022 | 15687 | 0.170 |
Why?
|
Confusion | 1 | 2002 | 279 | 0.170 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2014 | 3455 | 0.170 |
Why?
|
Chloroquine | 1 | 2021 | 277 | 0.170 |
Why?
|
Retinal Telangiectasis | 1 | 2019 | 25 | 0.170 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2024 | 854 | 0.160 |
Why?
|
Respiratory Aspiration | 1 | 2020 | 89 | 0.160 |
Why?
|
Spectrum Analysis | 1 | 2021 | 453 | 0.160 |
Why?
|
Brain Chemistry | 1 | 2002 | 959 | 0.160 |
Why?
|
Capsid | 1 | 2021 | 434 | 0.160 |
Why?
|
Consensus | 4 | 2024 | 3113 | 0.160 |
Why?
|
Choline | 3 | 2008 | 513 | 0.160 |
Why?
|
Carbon-Nitrogen Ligases | 1 | 2018 | 27 | 0.160 |
Why?
|
Early Diagnosis | 1 | 2023 | 1180 | 0.160 |
Why?
|
Multiple Sulfatase Deficiency Disease | 1 | 2018 | 2 | 0.160 |
Why?
|
Amino Acid Transport Systems, Acidic | 1 | 2018 | 30 | 0.160 |
Why?
|
Carbidopa | 1 | 2017 | 30 | 0.150 |
Why?
|
Sulfatases | 1 | 2018 | 44 | 0.150 |
Why?
|
Follow-Up Studies | 7 | 2024 | 39261 | 0.150 |
Why?
|
Patient Advocacy | 1 | 2020 | 358 | 0.150 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2006 | 892 | 0.150 |
Why?
|
Injections, Spinal | 1 | 2018 | 316 | 0.150 |
Why?
|
Hyperalgesia | 1 | 2022 | 530 | 0.150 |
Why?
|
Phagocytosis | 2 | 2017 | 1535 | 0.150 |
Why?
|
Tandem Mass Spectrometry | 1 | 2024 | 1189 | 0.150 |
Why?
|
Myelodysplastic Syndromes | 2 | 2024 | 1394 | 0.150 |
Why?
|
Psychomotor Disorders | 1 | 2018 | 149 | 0.150 |
Why?
|
Hand Strength | 1 | 2020 | 452 | 0.150 |
Why?
|
Brain Stem | 2 | 2019 | 857 | 0.140 |
Why?
|
Ion Channels | 1 | 2022 | 1043 | 0.140 |
Why?
|
Aged | 14 | 2020 | 169152 | 0.140 |
Why?
|
Posture | 1 | 2001 | 953 | 0.140 |
Why?
|
Pan troglodytes | 1 | 2017 | 224 | 0.140 |
Why?
|
Levodopa | 1 | 2017 | 217 | 0.140 |
Why?
|
Milk Proteins | 1 | 2017 | 163 | 0.140 |
Why?
|
Pilot Projects | 4 | 2022 | 8555 | 0.140 |
Why?
|
Cohort Studies | 7 | 2024 | 41335 | 0.140 |
Why?
|
Antiporters | 1 | 2018 | 278 | 0.140 |
Why?
|
Biotin | 1 | 2017 | 253 | 0.140 |
Why?
|
Mice, Knockout | 4 | 2021 | 14372 | 0.140 |
Why?
|
Thiamine | 1 | 2017 | 160 | 0.140 |
Why?
|
Muscle Weakness | 1 | 2019 | 413 | 0.140 |
Why?
|
Nerve Degeneration | 1 | 2021 | 748 | 0.140 |
Why?
|
Fibroblasts | 2 | 2018 | 4090 | 0.140 |
Why?
|
Eye Movements | 1 | 2020 | 508 | 0.140 |
Why?
|
Neurologic Examination | 1 | 2019 | 916 | 0.130 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2021 | 1173 | 0.130 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2022 | 608 | 0.130 |
Why?
|
Amidinotransferases | 1 | 2015 | 11 | 0.130 |
Why?
|
Muscle Strength | 1 | 2020 | 619 | 0.130 |
Why?
|
Endpoint Determination | 1 | 2019 | 597 | 0.130 |
Why?
|
Mice, Transgenic | 3 | 2015 | 9530 | 0.130 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 454 | 0.130 |
Why?
|
Substrate Specificity | 3 | 2015 | 1792 | 0.130 |
Why?
|
Lipids | 4 | 2017 | 3336 | 0.130 |
Why?
|
Gait | 1 | 2021 | 812 | 0.120 |
Why?
|
Antigens, CD34 | 1 | 2017 | 653 | 0.120 |
Why?
|
Chimerism | 1 | 2016 | 155 | 0.120 |
Why?
|
Case-Control Studies | 4 | 2017 | 22053 | 0.120 |
Why?
|
Gadolinium | 1 | 2020 | 959 | 0.120 |
Why?
|
Protons | 2 | 2016 | 1114 | 0.120 |
Why?
|
Child Behavior | 1 | 2021 | 847 | 0.120 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2017 | 629 | 0.120 |
Why?
|
Zebrafish Proteins | 1 | 2021 | 1006 | 0.120 |
Why?
|
Respiratory Function Tests | 1 | 2019 | 1683 | 0.120 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2015 | 190 | 0.120 |
Why?
|
Survival Analysis | 3 | 2019 | 10182 | 0.120 |
Why?
|
Speech Disorders | 1 | 2015 | 180 | 0.120 |
Why?
|
Mitochondrial Diseases | 1 | 2018 | 340 | 0.120 |
Why?
|
Cerebral Hemorrhage | 1 | 2006 | 2660 | 0.120 |
Why?
|
Hand | 1 | 2019 | 903 | 0.120 |
Why?
|
Optic Nerve | 1 | 2017 | 567 | 0.120 |
Why?
|
Microcephaly | 1 | 2018 | 425 | 0.120 |
Why?
|
Sciatic Nerve | 2 | 2022 | 613 | 0.110 |
Why?
|
Extremities | 1 | 2019 | 867 | 0.110 |
Why?
|
Headache | 1 | 2002 | 1249 | 0.110 |
Why?
|
Cerebral Cortex | 4 | 2014 | 5761 | 0.110 |
Why?
|
Diagnosis, Differential | 7 | 2017 | 12965 | 0.110 |
Why?
|
Coculture Techniques | 1 | 2017 | 1342 | 0.110 |
Why?
|
Glutathione Peroxidase | 1 | 2015 | 256 | 0.110 |
Why?
|
Antigens, Surface | 1 | 2017 | 1608 | 0.110 |
Why?
|
Sandhoff Disease | 2 | 2024 | 14 | 0.110 |
Why?
|
Longitudinal Studies | 4 | 2024 | 14495 | 0.110 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 691 | 0.110 |
Why?
|
Repressor Proteins | 1 | 2024 | 2981 | 0.110 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 8552 | 0.100 |
Why?
|
Hematologic Neoplasms | 1 | 2024 | 1895 | 0.100 |
Why?
|
Transplantation, Autologous | 1 | 2017 | 2116 | 0.100 |
Why?
|
Neuroglia | 2 | 2015 | 944 | 0.100 |
Why?
|
Depression, Chemical | 1 | 2011 | 185 | 0.100 |
Why?
|
Apoptosis | 1 | 2008 | 9501 | 0.100 |
Why?
|
Infant, Premature | 1 | 2001 | 2092 | 0.100 |
Why?
|
Drug Combinations | 1 | 2017 | 2025 | 0.100 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2015 | 1126 | 0.100 |
Why?
|
Alcohol Oxidoreductases | 2 | 2012 | 169 | 0.100 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 25942 | 0.100 |
Why?
|
Neuropsychological Tests | 1 | 2024 | 7021 | 0.100 |
Why?
|
Analysis of Variance | 2 | 2015 | 6238 | 0.100 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10827 | 0.100 |
Why?
|
Receptors, Immunologic | 1 | 2017 | 1411 | 0.090 |
Why?
|
Adrenal Glands | 1 | 2013 | 554 | 0.090 |
Why?
|
Immunosuppressive Agents | 2 | 2015 | 4166 | 0.090 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1617 | 0.090 |
Why?
|
Genes, Reporter | 1 | 2015 | 1529 | 0.090 |
Why?
|
Stereoisomerism | 1 | 2011 | 617 | 0.090 |
Why?
|
Calcium-Binding Proteins | 1 | 2015 | 1067 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2014 | 12293 | 0.090 |
Why?
|
Galactosylceramidase | 1 | 2010 | 23 | 0.090 |
Why?
|
Testis | 1 | 2013 | 794 | 0.090 |
Why?
|
Cell Line, Tumor | 2 | 2018 | 16939 | 0.090 |
Why?
|
Triplets | 1 | 2009 | 43 | 0.090 |
Why?
|
Microfilament Proteins | 1 | 2015 | 1135 | 0.090 |
Why?
|
Hair | 1 | 2013 | 497 | 0.090 |
Why?
|
Pain Perception | 1 | 2011 | 196 | 0.090 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2015 | 556 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2015 | 995 | 0.090 |
Why?
|
Anthracyclines | 1 | 2012 | 283 | 0.090 |
Why?
|
Psychometrics | 1 | 2019 | 3051 | 0.090 |
Why?
|
Dietary Supplements | 1 | 2022 | 3392 | 0.080 |
Why?
|
Age Factors | 2 | 2020 | 18416 | 0.080 |
Why?
|
Antibodies | 1 | 2017 | 2421 | 0.080 |
Why?
|
Microscopy, Confocal | 1 | 2015 | 1972 | 0.080 |
Why?
|
Acyl Coenzyme A | 1 | 2009 | 57 | 0.080 |
Why?
|
Sudden Infant Death | 2 | 2002 | 291 | 0.080 |
Why?
|
Protein Transport | 1 | 2015 | 1964 | 0.080 |
Why?
|
Prospective Studies | 3 | 2024 | 54303 | 0.080 |
Why?
|
Interviews as Topic | 1 | 2016 | 2659 | 0.080 |
Why?
|
Double-Blind Method | 2 | 2023 | 12427 | 0.080 |
Why?
|
Cerebellum | 2 | 2021 | 1496 | 0.080 |
Why?
|
Pain Measurement | 1 | 2019 | 3528 | 0.080 |
Why?
|
Psychotic Disorders | 1 | 2023 | 3193 | 0.080 |
Why?
|
Infertility, Male | 1 | 2011 | 396 | 0.080 |
Why?
|
Mice, Inbred C3H | 1 | 2009 | 915 | 0.080 |
Why?
|
Neuroanatomy | 1 | 2008 | 70 | 0.080 |
Why?
|
Image Enhancement | 1 | 2019 | 2881 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4573 | 0.080 |
Why?
|
Neurology | 1 | 2016 | 779 | 0.080 |
Why?
|
Movement Disorders | 1 | 2012 | 459 | 0.080 |
Why?
|
DNA-Binding Proteins | 2 | 2015 | 9585 | 0.080 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6068 | 0.080 |
Why?
|
Periaqueductal Gray | 1 | 2008 | 110 | 0.080 |
Why?
|
Self Report | 1 | 2019 | 3711 | 0.080 |
Why?
|
Monitoring, Ambulatory | 2 | 2002 | 353 | 0.080 |
Why?
|
Inositol | 1 | 2008 | 215 | 0.070 |
Why?
|
Evaluation Studies as Topic | 2 | 2007 | 1628 | 0.070 |
Why?
|
Genetic Testing | 1 | 2020 | 3531 | 0.070 |
Why?
|
Pain | 1 | 2022 | 5066 | 0.070 |
Why?
|
Contrast Media | 1 | 2020 | 5305 | 0.070 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 1 | 2008 | 133 | 0.070 |
Why?
|
Risk Assessment | 3 | 2023 | 24123 | 0.070 |
Why?
|
Membrane Glycoproteins | 1 | 2017 | 3707 | 0.070 |
Why?
|
Point Mutation | 1 | 2011 | 1594 | 0.070 |
Why?
|
Up-Regulation | 1 | 2015 | 4122 | 0.070 |
Why?
|
Cyclophosphamide | 1 | 2012 | 2221 | 0.070 |
Why?
|
Cricetinae | 1 | 2009 | 2427 | 0.070 |
Why?
|
Qualitative Research | 1 | 2016 | 2963 | 0.060 |
Why?
|
Data Collection | 1 | 2015 | 3315 | 0.060 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2008 | 663 | 0.060 |
Why?
|
Pyramidal Tracts | 1 | 2007 | 250 | 0.060 |
Why?
|
Sex Factors | 2 | 2009 | 10547 | 0.060 |
Why?
|
Mice, Inbred C57BL | 3 | 2015 | 22023 | 0.060 |
Why?
|
Ribonuclease H | 1 | 2024 | 50 | 0.060 |
Why?
|
Brain Mapping | 2 | 2012 | 6568 | 0.060 |
Why?
|
Forkhead Transcription Factors | 1 | 2012 | 1612 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2019 | 4925 | 0.060 |
Why?
|
Administration, Oral | 1 | 2011 | 4035 | 0.060 |
Why?
|
Psychomotor Performance | 1 | 2011 | 1878 | 0.050 |
Why?
|
Observer Variation | 1 | 2009 | 2601 | 0.050 |
Why?
|
Exodeoxyribonucleases | 1 | 2024 | 195 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7475 | 0.050 |
Why?
|
Antibody Formation | 1 | 2007 | 1400 | 0.050 |
Why?
|
Epilepsy | 1 | 2018 | 3267 | 0.050 |
Why?
|
Nerve Tissue Proteins | 1 | 2015 | 4407 | 0.050 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2006 | 352 | 0.050 |
Why?
|
Barium | 1 | 2022 | 62 | 0.050 |
Why?
|
Endothelial Cells | 1 | 2015 | 3539 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2013 | 3106 | 0.050 |
Why?
|
Stromal Cells | 1 | 2008 | 1326 | 0.050 |
Why?
|
Fatal Outcome | 3 | 2014 | 1832 | 0.050 |
Why?
|
Mammals | 2 | 2023 | 1131 | 0.050 |
Why?
|
France | 1 | 2023 | 511 | 0.050 |
Why?
|
Disability Evaluation | 1 | 2008 | 1826 | 0.050 |
Why?
|
Supine Position | 1 | 2001 | 205 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6544 | 0.050 |
Why?
|
Deglutition | 1 | 2022 | 208 | 0.050 |
Why?
|
Prone Position | 1 | 2001 | 196 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2016 | 58995 | 0.040 |
Why?
|
Blood Flow Velocity | 2 | 2001 | 1377 | 0.040 |
Why?
|
Intermediate Filaments | 1 | 2021 | 172 | 0.040 |
Why?
|
Delphi Technique | 1 | 2024 | 829 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2024 | 987 | 0.040 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2021 | 169 | 0.040 |
Why?
|
Aging | 1 | 2019 | 8651 | 0.040 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2001 | 281 | 0.040 |
Why?
|
Time Factors | 3 | 2011 | 40165 | 0.040 |
Why?
|
History, 21st Century | 1 | 2006 | 1575 | 0.040 |
Why?
|
Inflammation Mediators | 1 | 2008 | 1881 | 0.040 |
Why?
|
Macaca fascicularis | 1 | 2021 | 900 | 0.040 |
Why?
|
Echoencephalography | 1 | 1999 | 134 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2023 | 464 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 1998 | 11712 | 0.040 |
Why?
|
Gene Deletion | 1 | 2006 | 2668 | 0.040 |
Why?
|
Atrophy | 1 | 2023 | 1627 | 0.040 |
Why?
|
Neuroaxonal Dystrophies | 1 | 2018 | 26 | 0.040 |
Why?
|
Apnea | 1 | 2000 | 195 | 0.040 |
Why?
|
Polysomnography | 2 | 2002 | 1825 | 0.040 |
Why?
|
Folate Receptor 1 | 1 | 2018 | 40 | 0.040 |
Why?
|
Ocular Motility Disorders | 1 | 2020 | 143 | 0.040 |
Why?
|
Oxidoreductases Acting on Sulfur Group Donors | 1 | 2018 | 32 | 0.040 |
Why?
|
Bradycardia | 1 | 2000 | 299 | 0.040 |
Why?
|
Immunologic Factors | 1 | 2007 | 1588 | 0.040 |
Why?
|
Hemizygote | 1 | 2017 | 28 | 0.040 |
Why?
|
Databases, Factual | 1 | 2014 | 8035 | 0.040 |
Why?
|
Smoking | 1 | 2015 | 9073 | 0.040 |
Why?
|
Tetrahydrofolates | 1 | 2018 | 58 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2002 | 2262 | 0.040 |
Why?
|
Transgenes | 1 | 2021 | 1006 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2017 | 17790 | 0.040 |
Why?
|
Coenzyme A Ligases | 1 | 2017 | 45 | 0.040 |
Why?
|
History, 20th Century | 1 | 2006 | 2773 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2019 | 4107 | 0.040 |
Why?
|
Neural Pathways | 1 | 2008 | 3040 | 0.040 |
Why?
|
Infant, Premature, Diseases | 2 | 2002 | 708 | 0.040 |
Why?
|
Prognosis | 2 | 2023 | 29658 | 0.040 |
Why?
|
Europe | 1 | 2024 | 3441 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12531 | 0.030 |
Why?
|
Neurites | 2 | 2010 | 390 | 0.030 |
Why?
|
Herpesvirus 4, Human | 1 | 2022 | 1075 | 0.030 |
Why?
|
Infant, Small for Gestational Age | 1 | 1999 | 460 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2012 | 21025 | 0.030 |
Why?
|
Mastectomy, Radical | 1 | 1996 | 19 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2002 | 2852 | 0.030 |
Why?
|
Cerebral Palsy | 2 | 2012 | 471 | 0.030 |
Why?
|
Moyamoya Disease | 1 | 1999 | 255 | 0.030 |
Why?
|
Parietal Lobe | 1 | 2021 | 850 | 0.030 |
Why?
|
Gallbladder | 1 | 2017 | 305 | 0.030 |
Why?
|
Transcription Factors | 1 | 2015 | 12103 | 0.030 |
Why?
|
Permeability | 1 | 2017 | 719 | 0.030 |
Why?
|
Parents | 2 | 2016 | 3549 | 0.030 |
Why?
|
Syndrome | 1 | 2002 | 3280 | 0.030 |
Why?
|
Pregnancy | 3 | 2010 | 29749 | 0.030 |
Why?
|
Phosphoproteins | 1 | 2024 | 2440 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2012 | 3529 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 4713 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2009 | 3527 | 0.030 |
Why?
|
Remote Sensing Technology | 1 | 2016 | 92 | 0.030 |
Why?
|
Thalamus | 1 | 2021 | 1041 | 0.030 |
Why?
|
G(M2) Ganglioside | 1 | 2014 | 15 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2006 | 2782 | 0.030 |
Why?
|
Counseling | 1 | 2002 | 1548 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2017 | 587 | 0.030 |
Why?
|
Anterior Thalamic Nuclei | 1 | 2014 | 27 | 0.030 |
Why?
|
Cell Membrane | 1 | 2023 | 3682 | 0.030 |
Why?
|
Respiration | 1 | 2000 | 1654 | 0.030 |
Why?
|
Pregnancy Complications | 2 | 2010 | 2942 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2009 | 20080 | 0.030 |
Why?
|
Genes, Recessive | 1 | 2015 | 626 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7593 | 0.030 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2024 | 1463 | 0.030 |
Why?
|
Multiple Sclerosis | 1 | 2008 | 3204 | 0.030 |
Why?
|
Protein Structure, Secondary | 1 | 2015 | 1229 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2016 | 791 | 0.030 |
Why?
|
Glycine | 1 | 2015 | 662 | 0.030 |
Why?
|
Cell Line | 2 | 2021 | 15620 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2022 | 1879 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1933 | 0.020 |
Why?
|
Pedigree | 1 | 2019 | 4578 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 1998 | 4899 | 0.020 |
Why?
|
Ultrasonography, Prenatal | 1 | 1999 | 1745 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2022 | 5201 | 0.020 |
Why?
|
Dopamine Agents | 1 | 2012 | 189 | 0.020 |
Why?
|
Lymphocytes | 2 | 2010 | 2611 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1902 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2017 | 1431 | 0.020 |
Why?
|
Frontal Lobe | 1 | 2017 | 1420 | 0.020 |
Why?
|
Electroencephalography | 1 | 2006 | 6189 | 0.020 |
Why?
|
Fumonisins | 1 | 2010 | 10 | 0.020 |
Why?
|
Muscle Hypertonia | 1 | 2010 | 12 | 0.020 |
Why?
|
Remission Induction | 1 | 1996 | 2392 | 0.020 |
Why?
|
Clinical Protocols | 1 | 1996 | 1440 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3061 | 0.020 |
Why?
|
Genotype | 1 | 2024 | 12960 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2018 | 1974 | 0.020 |
Why?
|
Zebrafish | 1 | 2021 | 2997 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2020 | 6015 | 0.020 |
Why?
|
United States | 3 | 2024 | 72461 | 0.020 |
Why?
|
Failure to Thrive | 1 | 2010 | 140 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13630 | 0.020 |
Why?
|
Irritable Mood | 1 | 2010 | 194 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3800 | 0.020 |
Why?
|
Nerve Tissue | 1 | 2008 | 78 | 0.020 |
Why?
|
Cytokines | 1 | 2023 | 7343 | 0.020 |
Why?
|
Heart Rate | 1 | 2000 | 4179 | 0.020 |
Why?
|
Proteins | 1 | 2023 | 6029 | 0.020 |
Why?
|
Neurotransmitter Agents | 1 | 2012 | 663 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2017 | 2717 | 0.020 |
Why?
|
Chick Embryo | 1 | 2010 | 981 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2012 | 17624 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 2 | 2009 | 20509 | 0.020 |
Why?
|
Cognition | 2 | 2020 | 6957 | 0.020 |
Why?
|
JC Virus | 1 | 2008 | 87 | 0.020 |
Why?
|
Dementia, Vascular | 1 | 2008 | 123 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2016 | 1677 | 0.020 |
Why?
|
RNA Probes | 1 | 2007 | 111 | 0.020 |
Why?
|
AIDS Dementia Complex | 1 | 2008 | 153 | 0.020 |
Why?
|
Methionine | 2 | 2005 | 569 | 0.020 |
Why?
|
Carcinoma | 1 | 1998 | 2331 | 0.020 |
Why?
|
Stereotaxic Techniques | 1 | 2009 | 549 | 0.020 |
Why?
|
Treatment Failure | 1 | 2012 | 2648 | 0.020 |
Why?
|
Models, Molecular | 1 | 2015 | 5434 | 0.020 |
Why?
|
Base Pairing | 1 | 2005 | 140 | 0.020 |
Why?
|
Ferric Compounds | 1 | 2007 | 377 | 0.020 |
Why?
|
Neurotoxicity Syndromes | 1 | 2009 | 299 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2008 | 682 | 0.010 |
Why?
|
Child Development | 1 | 2016 | 2285 | 0.010 |
Why?
|
Sleep | 1 | 2020 | 4751 | 0.010 |
Why?
|
Cell Count | 1 | 2008 | 1835 | 0.010 |
Why?
|
Risk Factors | 3 | 2019 | 74359 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 1998 | 4878 | 0.010 |
Why?
|
Nanotechnology | 1 | 2007 | 709 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2005 | 1493 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 1996 | 11152 | 0.010 |
Why?
|
Base Sequence | 1 | 2012 | 12446 | 0.010 |
Why?
|
Cysteine | 1 | 2005 | 895 | 0.010 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2009 | 1854 | 0.010 |
Why?
|
Microelectrodes | 1 | 2000 | 304 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2009 | 2895 | 0.010 |
Why?
|
Platinum Compounds | 1 | 1998 | 95 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 1996 | 9276 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2000 | 956 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2009 | 13451 | 0.010 |
Why?
|
Biopsy | 1 | 2009 | 6771 | 0.010 |
Why?
|
Protein Binding | 1 | 2009 | 9335 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21392 | 0.010 |
Why?
|
Inflammation | 1 | 1996 | 10756 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2009 | 4938 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1998 | 675 | 0.010 |
Why?
|
Cerebral Infarction | 1 | 1999 | 982 | 0.010 |
Why?
|
Dementia | 1 | 2009 | 2649 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11071 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 9467 | 0.010 |
Why?
|
Substance-Related Disorders | 1 | 2010 | 4371 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 1999 | 942 | 0.010 |
Why?
|
Macrophages | 1 | 2008 | 5745 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2009 | 7850 | 0.010 |
Why?
|
Salvage Therapy | 1 | 1998 | 1268 | 0.010 |
Why?
|
Paclitaxel | 1 | 1998 | 1736 | 0.010 |
Why?
|
Melanoma | 1 | 2009 | 5697 | 0.010 |
Why?
|
Saccharomyces | 1 | 1969 | 63 | 0.000 |
Why?
|
Disease-Free Survival | 1 | 1998 | 6828 | 0.000 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2002 | 3986 | 0.000 |
Why?
|
Recurrence | 1 | 1998 | 8482 | 0.000 |
Why?
|
Molecular Biology | 1 | 1969 | 580 | 0.000 |
Why?
|
Sensitivity and Specificity | 1 | 2000 | 14660 | 0.000 |
Why?
|
Enzyme Repression | 1 | 1969 | 30 | 0.000 |
Why?
|
Transferases | 1 | 1969 | 72 | 0.000 |
Why?
|
Electrophoresis | 1 | 1969 | 234 | 0.000 |
Why?
|
Nucleosides | 1 | 1969 | 131 | 0.000 |
Why?
|
Ligases | 1 | 1969 | 332 | 0.000 |
Why?
|
Nucleotidyltransferases | 1 | 1969 | 244 | 0.000 |
Why?
|
Genes, Dominant | 1 | 1969 | 863 | 0.000 |
Why?
|
Homocysteine | 1 | 1969 | 640 | 0.000 |
Why?
|
Kinetics | 1 | 1969 | 6377 | 0.000 |
Why?
|